Warren Buffett's Berkshire Hathaway reportedly passed on an opportunity to buy Tiffany following the jeweler receiving a takeover offer from LVMH. The jeweler approached Berkshire Hathaway and four other potential bidders after rejecting LVMH's first offer, though none were interested in topping the $135 per share bid. ...
Urovant Sciences (NASDAQ: UROV): Urovant shares jumped 18% on the last day of the year after submitting a New Drug Application (NDA) to the FDA seeking approval for its once-daily, 75 mg vibegron, a treatment for patients with overactive bladder. "Our NDA submission for vibegron is a significant milestone for our company and brings us one step closer to potentially providing a new oral therapy to highly ...
| |
Former Lehman Brothers executive reveals one of Wall Street's best kept secrets. A proven system for turning $1,000 into $1.3 Million (or more) - without touching the stock market.
In fact, this system is responsible for the most profitable investment of all time! (ad)
| |
Is it too late to make a good profit with cannabis stocks? NO WAY. In fact, the best legal-marijuana stocks for your money are still cheap, given their huge sales prospects. (ad)
| | | |
As the market, and economy moves into an expected, but unprecedented eleventh year of its bullish trend, a big question I see a lot of smart investors asking right now is what the right approach to take to the market is. With most economic indicators showing signs of continued strength, trade progress expected to reduce escalating costs and foreign risk exposure due to tariffs, and ongoing, accommodative interest rate policy in place, it's pretty easy to be optimistic; that's why I think a lot of analysts are expecting the market to keep going up in 2020.
| |
ServiceSource International, Inc. operates as a digital customer journey experience company. Its solutions include lead generation, inside sales, outsourced sales operations, customer onboarding, customer success management, cross-sell and upsell, warranty conversion, account-based marketing, and channel recruitment and enablement, as well as renewals management services, such as the sale of maintenance and support service contracts for the products used by its clients' end-users. | |
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.
| | Trend Following Picks
Reversal Picks
| | | | Already subscribed to our premium service?
Not a TradersPro subscriber yet?
| | | | |
This email was sent to its028@gmail.com by Investiv, LLC
Disclaimers
Investing is Inherently Risky
There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.
Hypothetical Results Are Reported
Results and examples used in the Company's advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage.
The Company's simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading.
Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company's software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.
Offers Disinterested Commentary and Analysis
The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one's own recommendations.
The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company's principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase.
Disclaimers, Terms & Conditions | Privacy Policy
Copyright © 2019 | |
|
|
|
|
没有评论:
发表评论